Jill Fisher explains how clinical drug trials attract disproportionate participation by racial and ethnic minorities who then disproportionately assume risks of participating in these trials, often just to stay financially afloat.
Listen to podcast here https://pennreg.org/episode-6/?fbclid=IwAR31bTRJrLtX23iahfnn17I7PF_Sfcn0XeP9DzBeW9E6ylLpVsn_3DzDCxU